hydroxychloroquine has been researched along with Retinal Detachment in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Retinal Detachment: Separation of the inner layers of the retina (neural retina) from the pigment epithelium. Retinal detachment occurs more commonly in men than in women, in eyes with degenerative myopia, in aging and in aphakia. It may occur after an uncomplicated cataract extraction, but it is seen more often if vitreous humor has been lost during surgery. (Dorland, 27th ed; Newell, Ophthalmology: Principles and Concepts, 7th ed, p310-12).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The case is presented of a 56 year-old patient diagnosed with rhegmatogenous retinal detachment and on treatment with hydroxychloroquine (HCQ)." | 7.83 | Signs of hydroxychloroquine toxicity in a patient with rhegmatogenous retinal detachment. ( Campos-Pavón, J; Redondo-García, I; Sambricio, J, 2016) |
| "The case is presented of a 56 year-old patient diagnosed with rhegmatogenous retinal detachment and on treatment with hydroxychloroquine (HCQ)." | 3.83 | Signs of hydroxychloroquine toxicity in a patient with rhegmatogenous retinal detachment. ( Campos-Pavón, J; Redondo-García, I; Sambricio, J, 2016) |
| "To describe a case of hydroxychloroquine retinopathy combined with retinal pigment epithelium (RPE) detachment and evaluate possible causes of pigment epithelium detachment." | 1.38 | Hydroxychloroquine retinopathy combined with retinal pigment epithelium detachment. ( Ko, MK; Lee, BR; Lee, WJ, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campos-Pavón, J | 1 |
| Sambricio, J | 1 |
| Redondo-García, I | 1 |
| Lee, WJ | 1 |
| Ko, MK | 1 |
| Lee, BR | 1 |
2 other studies available for hydroxychloroquine and Retinal Detachment
| Article | Year |
|---|---|
Signs of hydroxychloroquine toxicity in a patient with rhegmatogenous retinal detachment.
Topics: Exudates and Transudates; Eye Diseases, Hereditary; Female; Humans; Hydroxychloroquine; Light Coagul | 2016 |
Hydroxychloroquine retinopathy combined with retinal pigment epithelium detachment.
Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Hydroxychloroquine; Retinal Detachment; Retinal Dis | 2012 |